$ASAN Cashflow Statement | Understand Stock

$ASAN

$11.86 -$0.15 (1.25%) Close

$ASAN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jan 31, 2026	FY2025 12 months to Jan 31, 2025	FY2024 12 months to Jan 31, 2024	FY2023 12 months to Jan 31, 2023	FY2022 12 months to Jan 31, 2022
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Allowance for expected credit losses
Depreciation and amortization
Amortization of deferred contract acquisition costs
Stock-based compensation expense
Net accretion of discount on marketable securities
Change in fair value of redeemable convertible preferred stock warrant liability
Non-cash lease expense
Impairment of long-lived assets
Amortization of discount on revolving credit facility and term loan issuance costs
Non-cash interest expense
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Operating lease liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities
Purchases of marketable securities
Sales of marketable securities
Maturities of marketable securities
Purchases of property and equipment
Capitalized internal-use software costs
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from term loan, net of issuance costs
Repayment of term loan
Proceeds from private placement—related party, net of offering costs
Proceeds from issuance of convertible notes — related party
Repurchases of common stock
Proceeds from exercise of stock options
Proceeds from employee stock purchase plan
Taxes paid related to net share settlement of equity awards
Net cash (used in) provided by financing activities

Effect of foreign exchange rates on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash
Beginning of period
End of period
Supplemental cash flow data
Cash paid for income taxes
Cash paid for interest
Supplemental non-cash investing and financing information
Purchase of property and equipment in accounts payable and accrued expenses
Vesting of early exercised stock options
Conversion of redeemable convertible preferred stock warrant liability to redeemable convertible preferred stock as a result of warrant exercise
Issuance of common stock upon conversion of convertible notes — related party
Stock-based compensation expense capitalized for software development

Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents
Restricted cash

Comments